Cargando…
Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait
BACKGROUND: Gla-domainless factor (F) Xa (GD-FXa) was proposed as a trap to endogenous anticoagulant tissue factor pathway inhibitor (TFPI) to restore thrombin generation in hemophilia. Using computational chemistry and experimental approaches, we previously showed that S195A GD-FXa also binds TFPI...
Autores principales: | Dagher, Marie-Claire, Ersayin, Atanur, Seyve, Landry, Castellan, Mathieu, Moreau, Cyril, Choisnard, Luc, Thielens, Nicole, Marlu, Raphaël, Polack, Benoît, Thomas, Aline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568284/ https://www.ncbi.nlm.nih.gov/pubmed/37841511 http://dx.doi.org/10.1016/j.rpth.2023.102175 |
Ejemplares similares
-
Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition
por: Rashid, Qudsia, et al.
Publicado: (2014) -
Efficacy of Oral Factor Xa Inhibitor for Venous Thromboembolism in a Patient with Antithrombin Deficiency
por: Minami, Kentaro, et al.
Publicado: (2018) -
Fibrinography: A Multiwavelength Light-Scattering Assay of Fibrin Structure
por: Dassi, Carhel, et al.
Publicado: (2019) -
Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
por: Salta, Stella, et al.
Publicado: (2018) -
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro
por: Noguchi-Sasaki, Mariko, et al.
Publicado: (2018)